Battle of the γδ T cell subsets in the gut.
暂无分享,去创建一个
[1] Caixia Zhu,et al. TCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets , 2022, Science.
[2] A. Schulz,et al. A fetal wave of human type 3 effector γδ cells with restricted TCR diversity persists into adulthood , 2021, Science immunology.
[3] M. Roncalli,et al. NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer. , 2019, JCI insight.
[4] I. Prinz,et al. Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies , 2019, Nature Reviews Drug Discovery.
[5] S. Coffelt,et al. γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer , 2019, Nature Reviews Cancer.
[6] L. Gangoda,et al. Single-Cell Transcriptomics Identifies the Adaptation of Scart1+ Vγ6+ T Cells to Skin Residency as Activated Effector Cells. , 2019, Cell reports.
[7] M. Meyerson,et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells , 2019, Cell.
[8] B. Silva-Santos,et al. IL-17+ γδ T cells as kick-starters of inflammation , 2017, Nature Immunology.
[9] F. Qiu,et al. γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. , 2014, Immunity.
[10] Julia M. Lewis,et al. Regulation of Cutaneous Malignancy by γδ T Cells , 2001, Science.